{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:09:05Z","timestamp":1767172145692,"version":"build-2238731810"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fundacion Probitas"},{"name":"Ohio State University Public Health Preparedness for Infectious Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Improved point-of-care diagnostic tests for tuberculosis (TB) in severe immune suppressed people living with HIV (PLWH) are needed to decrease morbidity and mortality outcomes. The aim of the study is to evaluate the performance of the lipoarabinomannan antigen test (LAM-test) with and without \u03b1-mannosidase pre-treated urine in a cohort of PLWH in primary care clinics in Guatemala. We further determined TB incidence, and mortality rates and its risk factors in PLWH with TB symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Prospective longitudinal study of PLWH with TB symptoms. Urine samples were collected at 2 HIV sites to test the sensitivity of the LAM-test in urine with and without \u03b1-mannosidase pre-treatment. A composite reference standard of either a positive\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      complex culture and\/or GeneXpert\n                      <jats:sup>\u00ae<\/jats:sup>\n                      MTB\/RIF (Xpert, Cepheid, Sunnyvale, CA, USA) results was used in the LAM-test diagnostic accuracy studies. Cox proportional hazards regression was used to study mortality predictors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The overall sensitivity of the LAM-test was of 56.1% with 95% CI of (43.3\u201368.3). There were no differences in the LAM-test sensitivity neither by hospital nor by CD4 T cell values. LAM-test sensitivity in PLWH with\u2009&lt;\u2009200 CD4 T cells\/\u00b5l was of 62.2% (95% CI 46.5\u201376.2). There were no significant differences in sensitivity when comparing LAM-test results obtained from untreated vs. \u03b1-mannosidase treated urine [55.2% (95% CI 42.6\u201367.4) vs. 56.9% (95% CI 44\u201369.2), respectively]. TB incidence in our cohort was of 21.4\/100 person years (PYs) (95% CI 16.6\u201327.6), and mortality rate was of 11.1\/100 PYs (95% CI 8.2\u201315.0). Importantly, PLWH with a positive LAM-test result had an adjusted hazard ratio (aHR) of death of 1.98 (1.0\u20133.8) with a significant\n                      <jats:italic>p<\/jats:italic>\n                      value of 0.044 when compared to PLWH with a negative LAM-test result.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study, \u03b1-mannosidase treatment of urine did not significantly increase the LAM-test performance, however; this needs to be further evaluated in a large-scale study due to our study limitations. Importantly, high rates of TB incidence and mortality were found, and a positive LAM-test result predicted mortality in PLWH with TB clinical symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-020-00318-8","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T09:04:25Z","timestamp":1603098265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using \u03b1-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8263-3140","authenticated-orcid":false,"given":"Juan Ignacio","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Mel\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Mej\u00eda-Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holden V.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabeen","family":"Sidiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Mazariegos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"L\u00f3pez-T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Forno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan-Miquel","family":"Balada-Llasat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Rodolfo","family":"Mej\u00eda-Villatoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi B.","family":"Torrelles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"issue":"2","key":"318_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/QAI.0b013e3182638ec7","volume":"61","author":"S Saito","year":"2012","unstructured":"Saito S, Howard AA, Reid MJA, Elul B, Scardigli A, Verkuijl S, et al. TB diagnostic capacity in sub-Saharan African HIV care settings. JAIDS J Acquir Immune Defic Syndr. 2012;61(2):216\u201320.","journal-title":"JAIDS J Acquir Immune Defic Syndr."},{"issue":"1","key":"318_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12879-016-1617-9","volume":"16","author":"A Kunkel","year":"2016","unstructured":"Kunkel A, Abel zur Wiesch P, Nathavitharana RR, Marx FM, Jenkins HE, Cohen T. Smear positivity in paediatric and adult tuberculosis: systematic review and meta-analysis. BMC Infect Dis. 2016;16(1):282.","journal-title":"BMC Infect Dis"},{"key":"318_CR3","unstructured":"World Health Organization. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV. Policy update 2019. Who. World Health Organization; 2019. 44 p."},{"issue":"4","key":"318_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1002776","volume":"16","author":"A Gupta-Wright","year":"2019","unstructured":"Gupta-Wright A, Corbett EL, Wilson D, Van Oosterhout JJ, Dheda K, Huerga H, et al. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: derivation and external validation cohort study. PLoS Med. 2019;16(4):1\u201320.","journal-title":"PLoS Med."},{"issue":"4","key":"318_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femspd\/fty031","volume":"76","author":"S Gupta","year":"2018","unstructured":"Gupta S, Rodriguez GM. Mycobacterial extracellular vesicles and host pathogen interactions. Pathog Dis. 2018;76(4):1\u20136.","journal-title":"Pathog Dis."},{"issue":"5","key":"318_CR6","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.4049\/jimmunol.1601199","volume":"198","author":"JJ Athman","year":"2017","unstructured":"Athman JJ, Sande OJ, Groft SG, Reba SM, Nagy N, Wearsch PA, et al. Mycobacterium tuberculosis membrane vesicles Inhibit T cell activation. J Immunol. 2017;198(5):2028\u201337.","journal-title":"J Immunol."},{"issue":"4","key":"318_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femspd\/fty026","volume":"76","author":"J Turner","year":"2018","unstructured":"Turner J, Torrelles JB. Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis. Pathog Dis. 2018;76(4):1\u201315.","journal-title":"Pathog Dis."},{"key":"318_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/trstmh\/trw008","volume":"110","author":"SD Lawn","year":"2015","unstructured":"Lawn SD, Gupta-Wright A. Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with hiv and advanced immunodeficiency: evidence and implications. Trans R Soc Trop Med Hyg. 2015;110:180\u20135.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"318_CR9","first-page":"CD011420","volume":"2016","author":"M Shah","year":"2016","unstructured":"Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. Cochrane Database Syst Rev. 2016;2016(5):CD011420.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"318_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-12-103","volume":"12","author":"SD Lawn","year":"2012","unstructured":"Lawn SD. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis. 2012;12(1):1.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"318_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S1473-3099(11)70251-1","volume":"12","author":"SD Lawn","year":"2012","unstructured":"Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis. 2012;12(3):201\u20139.","journal-title":"Lancet Infect Dis."},{"issue":"5","key":"318_CR12","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1183\/09031936.00201711","volume":"40","author":"JG Peter","year":"2012","unstructured":"Peter JG, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, Kraus S, et al. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients. Eur Respir J. 2012;40(5):1211\u201320.","journal-title":"Eur Respir J"},{"issue":"4","key":"318_CR13","doi-asserted-by":"publisher","first-page":"fty026","DOI":"10.1093\/femspd\/fty026","volume":"76","author":"J Turner","year":"2018","unstructured":"Turner J, Torrelles JB. Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis. Pathog Dis. 2018;76(4):fty026.","journal-title":"Pathog Dis."},{"issue":"1","key":"318_CR14","doi-asserted-by":"publisher","first-page":"18012","DOI":"10.1038\/s41598-019-54537-9","volume":"9","author":"JI Garc\u00eda","year":"2019","unstructured":"Garc\u00eda JI, Kelley HV, Mel\u00e9ndez J, de Le\u00f3n RAA, Castillo A, Sidiki S, et al. Improved Alere Determine Lipoarabinomannan Antigen Detection Test for the Diagnosis of Human and Bovine Tuberculosis by Manipulating Urine and Milk. Sci Rep. 2019;9(1):18012.","journal-title":"Sci Rep."},{"key":"318_CR15","unstructured":"World Health Organization (WHO). Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Vol. 01. 2011."},{"issue":"9","key":"318_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/trstmh\/tru110","volume":"108","author":"GA Ansa","year":"2014","unstructured":"Ansa GA, Walley JD, Siddiqi K, Wei X. Delivering TB\/HIV services in Ghana: a comparative study of service delivery models. Trans R Soc Trop Med Hyg. 2014;108(9):560\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"318_CR17","first-page":"281","volume":"23","author":"MT Montales","year":"2015","unstructured":"Montales MT, Chaudhury A, Beebe A, Patil S, Patil N. HIV-associated TB syndemic: a growing clinical challenge worldwide. Front Public Heal. 2015;23(3):281.","journal-title":"Front Public Heal."},{"issue":"Suppl 1","key":"318_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10461-018-2190-6","volume":"22","author":"JM Ikeda","year":"2018","unstructured":"Ikeda JM, Racancoj O, Welty S, Page K, Hearst N, McFarland W. Risk behaviors and perceptions among self-identified men who have sex with men (MSM), bisexuals, transvestites, and transgender women in Western Guatemala. AIDS Behav. 2018;22(Suppl 1):45\u201356.","journal-title":"AIDS Behav"},{"issue":"Suppl 1","key":"318_CR19","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1007\/s10461-013-0595-9","volume":"18","author":"JM Ikeda","year":"2014","unstructured":"Ikeda JM, Tellez CAL, Hudes ES, Page K, Evans J, Racancoj O, et al. Impact of integrating HIV and TB care and treatment in a regional tuberculosis hospital in rural Guatemala. AIDS Behav. 2014;18(Suppl 1):S96\u2013103.","journal-title":"AIDS Behav"},{"key":"318_CR20","unstructured":"Ministerio de Salud P\u00fablica y Asistencia Social de Guatemala (MSPAS). Manual de Tratamiento Antiretroviral y de Infecciones Oportunistas en Guatemala. Guatemala City; 2011."},{"key":"318_CR21","unstructured":"Malhotra B, World Health Organization. Department of HIV\/AIDS., Stop TB Initiative (World Health Organization). Guidelines for intensified tuberculosis case-finding and isoniazid preventative therapy for people living with HIV in resource-constrained settings. Department of HIV\/AIDS; 2011."},{"issue":"3","key":"318_CR22","first-page":"187","volume":"1","author":"Z Ghazanfari","year":"2010","unstructured":"Ghazanfari Z, Haghdoost AA, Alizadeh SM, Atapour J, Zolala F. A comparison of HbA1c and fasting blood sugar tests in general population. Int J Prev Med. 2010;1(3):187\u201394.","journal-title":"Int J Prev Med."},{"issue":"1","key":"318_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/1741-7015-11-231","volume":"11","author":"SD Lawn","year":"2013","unstructured":"Lawn SD, Kerkhoff AD, Vogt M, Wood R. HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays. BMC Med. 2013;11(1):231.","journal-title":"BMC Med."},{"issue":"1","key":"318_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-09895-7","volume":"7","author":"AD Kerkhoff","year":"2017","unstructured":"Kerkhoff AD, Barr DA, Schutz C, Burton R, Nicol MP, Lawn SD, et al. Disseminated tuberculosis among hospitalised HIV patients in South Africa: a common condition that can be rapidly diagnosed using urine-based assays. Sci Rep. 2017;7(1):1\u201311.","journal-title":"Sci Rep."},{"issue":"3","key":"318_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1183\/09031936.00003315","volume":"46","author":"I Kroidl","year":"2015","unstructured":"Kroidl I, Clowes P, Reither K, Mtafya B, Rojas-Ponce G, Ntinginya EN, et al. Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania. Eur Respir J. 2015;46(3):761\u201370.","journal-title":"Eur Respir J"},{"key":"318_CR26","doi-asserted-by":"crossref","first-page":"CD011420","DOI":"10.1002\/14651858.CD010697.pub2","volume":"2016","author":"M Shah","year":"2016","unstructured":"Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. Cochrane Database of Systematic Reviews. 2016;2016:CD011420.","journal-title":"Cochrane Database of Systematic Reviews."},{"issue":"1","key":"318_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12916-015-0432-2","volume":"13","author":"SD Lawn","year":"2015","unstructured":"Lawn SD, Kerkhoff AD, Burton R, Schutz C, van Wyk G, Vogt M, et al. Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB\/RIF: a prospective cohort in South Africa. BMC Med. 2015;13(1):192.","journal-title":"BMC Med."},{"key":"318_CR28","unstructured":"World Health Organization (WHO). Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV. Policy update (2019). 2018."},{"key":"318_CR29","unstructured":"Programa Nacional de Prevenci\u00f3n y Control de ITS VIH y SIDA (PNS). Informe Nacional de la Cascada del Continuo de Atenci\u00f3n en VIH. Vol. 24. 2018."},{"issue":"8","key":"318_CR30","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/glycob\/cws078","volume":"22","author":"JB Torrelles","year":"2012","unstructured":"Torrelles JB, Sieling PA, Zhang N, Keen MA, McNeil MR, Belisle JT, et al. Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells. Glycobiology. 2012;22(8):1118\u201327.","journal-title":"Glycobiology"},{"issue":"3","key":"318_CR31","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.4049\/jimmunol.177.3.1805","volume":"177","author":"JB Torrelles","year":"2006","unstructured":"Torrelles JB, Azad AK, Schlesinger LS. Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J Immunol. 2006;177(3):1805\u201316.","journal-title":"J Immunol."},{"issue":"2","key":"318_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1051\/medsci\/20153102003","volume":"31","author":"R Brosch","year":"2015","unstructured":"Brosch R, Guilhot C. Les bacilles de la tuberculose bovine: Une \u00e9volution aux d\u00e9pens de la transmissibilit\u00e9 chez l\u2019homme. Medecine\/Sciences. 2015;31(2):123\u20136.","journal-title":"Medecine\/Sciences."},{"issue":"2","key":"318_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1021\/acsinfecdis.9b00355","volume":"6","author":"P De","year":"2020","unstructured":"De P, Shi L, Boot C, Ordway D, Mcneil M, Chatterjee D. Comparative structural study of terminal ends of Lipoarabinomannan from mice infected lung tissues and urine of a tuberculosis positive patient. ACS Infect Dis. 2020;6(2):291\u2013301.","journal-title":"ACS Infect Dis."},{"key":"318_CR34","unstructured":"World Health Orgnaization (WHO). Global Tuberculosis Report 2019."},{"issue":"3","key":"318_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/trstmh\/trv108","volume":"110","author":"K L\u00f6nnroth","year":"2015","unstructured":"L\u00f6nnroth K, Raviglione M. The WHO\u2019s new end tb strategy in the post-2015 era of the sustainable development goals. Trans R Soc Trop Med Hyg. 2015;110(3):148\u201350.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"318_CR36","doi-asserted-by":"publisher","first-page":"723","DOI":"10.5588\/ijtld.17.0835","volume":"22","author":"K Floyd","year":"2018","unstructured":"Floyd K, Glaziou P, Houben RMGJ, Sumner T, White RG, Raviglione M. Global tuberculosis targets and milestones set for 2016\u20132035: definition and rationale. Int J Tuberc Lung Dis. 2018;22(7):723\u201330.","journal-title":"Int J Tuberc Lung Dis."},{"key":"318_CR37","volume-title":"A guide to monitoring and evaluation for collaborative TB\/HIV activities","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. A guide to monitoring and evaluation for collaborative TB\/HIV activities. Geneva: WHO. World Health Organization; 2009."},{"key":"318_CR38","volume-title":"WHO | WHO policy on collaborative TB\/HIV activities","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. WHO | WHO policy on collaborative TB\/HIV activities. World Health Organization: WHO; 2012."},{"issue":"1","key":"318_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4314\/ahs.v17i1.26","volume":"17","author":"K Said","year":"2017","unstructured":"Said K, Verver S, Kalingonji A, Lwilla F, Mkopi A, Charalambous S, et al. Tuberculosis among HIVHIV-infected population: incidence and risk factors in rural Tanzania. Afr Health Sci. 2017;17(1):208\u201315.","journal-title":"Afr Health Sci."},{"issue":"3","key":"318_CR40","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1371\/journal.pone.0173309","volume":"12","author":"I Pathmanathan","year":"2017","unstructured":"Pathmanathan I, Dokubo EK, Shiraishi RW, Agolory SG, Auld AF, Onotu D, et al. Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012. PLoS ONE. 2017;12(3):2004\u201312.","journal-title":"PLoS ONE"},{"issue":"10024","key":"318_CR41","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/S0140-6736(15)01092-2","volume":"387","author":"JG Peter","year":"2016","unstructured":"Peter JG, Zijenah LS, Chanda D, Clowes P, Lesosky M, Gina P, et al. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. Lancet. 2016;387(10024):1187\u201397.","journal-title":"Lancet"},{"issue":"1","key":"318_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-016-0603-9","volume":"14","author":"A Gupta-Wright","year":"2016","unstructured":"Gupta-Wright A, Peters JA, Flach C, Lawn SD. Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. BMC Med. 2016;14(1):1\u201311.","journal-title":"BMC Med."},{"key":"318_CR43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijid.2017.04.017","volume":"59","author":"G Suwanpimolkul","year":"2017","unstructured":"Suwanpimolkul G, Kawkitinarong K, Manosuthi W, Sophonphan J, Gatechompol S, Ohata PJ, et al. Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network. Int J Infect Dis. 2017;59:96\u2013102.","journal-title":"Int J Infect Dis."},{"issue":"11","key":"318_CR44","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.5588\/ijtld.18.0099","volume":"22","author":"RW Kubiak","year":"2018","unstructured":"Kubiak RW, Herbeck JT, Coleman SM, Ross D, Freedberg K, Bassett IV, et al. Urinary LAM grade, culture positivity, and mortality among HIV-infected South African out-patients. Int J Tuberc Lung Dis. 2018;22(11):1366\u201373.","journal-title":"Int J Tuberc Lung Dis."},{"key":"318_CR45","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S1473-3099(19)30001-5","volume":"19","author":"T Broger","year":"2019","unstructured":"Broger T, Reipold I, Ongarello S, Mbchb S, Mbchb S, Mbchb AW, et al. Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study. Artic Lancet Infect Dis. 2019;19:852\u201361.","journal-title":"Artic Lancet Infect Dis."}],"updated-by":[{"DOI":"10.1186\/s12981-022-00466-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000}}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00318-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-020-00318-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00318-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T02:16:20Z","timestamp":1666577780000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-020-00318-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1186\/s12981-020-00318-8","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12981-022-00466-z","URL":"https:\/\/doi.org\/10.1186\/s12981-022-00466-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethical Review Committee of the Guatemalan Ministry of Health and Social Welfare approved this study protocol with approval number 45-2014. The Institutional Review Board at The Ohio State University approved this study protocol with approval number 2013H0251.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consented and agreed to publish this research study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}